Electrosurgical Technology

Controlled tissue resection system minimizes collateral tissue damage

Published in Cancer Weekly, November 5th, 2002

ACMI announced it has received an excellent response from surgeons using its Vista CTR (Controlled Tissue Resection) system for performing bipolar resection of the prostate and bladder tumors (TURP/TURBT).

The Vista CTR system combines the power of cutting-edge bipolar technology with ACMI's market leading cysto-resection systems. The product uses Coblation technology, licensed from ArthroCare Corporation (ARTC), and will be exclusively marketed by ACMI into urology. Coblation technology is a next-generation, bipolar electrosurgical technology that minimizes collateral tissue damage using a non-heat driven process. It has proven effective in over 1.75 million...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-11-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry